ARMK
Aramark
ARMK has the edge over RKLB overall, supported by lower modeled downside and stronger modeled upside.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
ARMK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
ARMK's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ARMK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $22.71 | -58% |
| Forward | 19x | $53.88 | — |
| Fair | 33x | $47.38 | -12% |
| Current | 38x | $53.88 | — |
| Expensive | 55x | $78.71 | +46% |
Historical ranges are pointers, not guarantees.
ARMK's PE is in its fair range at 38x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
ARMK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARMK, with profitability holding steady.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RKLB has the edge over ARMK on the outlook, with more favorable profitability expectations.
ARMK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.82 | +97% |
| Q2 2026 | $1.43 | +5.9% |
| Q1 2026 | $1.34 | +3.1% |
| Q4 2025 | $1.19 | -6.3% |
| Q3 2025 | $1.22 | +23% |
| Q2 2025 | $1.35 | +2.3% |
| Q1 2025 | $1.30 | -46% |
| Q4 2024 | $1.27 | -47% |
| Q3 2024 | $0.99 | -61% |
ARMK has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
ARMK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $5.1B | +9.3% |
| Q1 2026 | $4.9B | +15% |
| Q4 2025 | $4.8B | +6.1% |
| Q3 2025 | $5B | +14% |
| Q2 2025 | $4.6B | +5.7% |
| Q1 2025 | $4.3B | +1.9% |
| Q4 2024 | $4.6B | +3.3% |
| Q3 2024 | $4.4B | -9.9% |
ARMK's revenue has grown year over year for seven quarters in a row: $5.1B last quarter, up 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.3% | +0.3 points |
| Q1 2026 | 4.5% | +0.4 points |
| Q4 2025 | 4.5% | -0.3 points |
| Q3 2025 | 4.3% | -0.6 points |
| Q2 2025 | 4% | +0.3 points |
| Q1 2025 | 4.1% | +0.3 points |
| Q4 2024 | 4.8% | +1 points |
| Q3 2024 | 5% | -0.7 points |
ARMK has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over ARMK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
ARMK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $4.8M | +$39.5M |
| Q1 2026 | $299M | +113% |
| Q4 2025 | -$904.4M | -$197.3M |
| Q3 2025 | $1B | +17% |
| Q2 2025 | -$34.7M | -162% |
| Q1 2025 | $140.1M | +4.7% |
| Q4 2024 | -$707M | +$65.7M |
| Q3 2024 | $882.3M | -0.5% |
ARMK has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
ARMK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +2.1M shares |
| 1 year | +1.2% | +3.2M shares |
| 3 years | +2.2% | +5.8M shares |
| 5 years | +4.3% | +11.2M shares |
| Available history | +6.6% | +16.5M shares |
ARMK has the edge over RKLB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $913,000 |
| Q1 2026 | $25.1M |
| Q4 2025 | $41.3M |
| Q3 2025 | $29.7M |
| Q2 2025 | $30.9M |
| Q3 2021 | — |
| Q2 2021 | — |
| Q3 2020 | — |
ARMK spent $97M buying back its own shares over the past year.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has 652M diluted shares, up 23% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ARMK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.2x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 4.6x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.5x | High |
| Q3 2024 | 4.0x | High |
ARMK's net debt is about 4.0 years of its operating earnings (EBITDA), down from 4.6 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARMK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.0 | Neutral |
| Stochastic | 23.6 | Neutral |
ARMK's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
ARMK PE vs Industrials Sector
| Metric | ARMK | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 24x | 57% above |
| PE % | 55 | 58 | 3 pts below |
ARMK is trading at 38x earnings, a 57% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
ARMK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.2 | 0.6% below |
| 20 week MA | $56.3 | 4.4% below |
| 50 week MA | $48.6 | 11% above |
| 100 week MA | $43.4 | 24% above |
| 200 week MA | $37.2 | 45% above |
ARMK has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 45% above its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
ARMK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.4 | $27.2 | -13% |
| 2021 | $27.2 | $26.0 | -4.2% |
| 2022 | $26.0 | $30.0 | +15% |
| 2023 | $30.0 | $28.1 | -6.2% |
| 2024 | $28.1 | $37.4 | +33% |
| 2025 | $37.4 | $37.4 | 0% |
| 2026 YTD | $37.4 | $53.9 | +44% |
ARMK has the edge over RKLB on returns for 2026, with the stronger performance.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB's yearly returns have swung widely, from +392% in 2024 to −69% in 2022. It's down 9.3% so far in 2026.